American Journal of Medical Case Reports. 2021, 9(4), 229-231
DOI: 10.12691/AJMCR-9-4-6
A Classical Wide Complex Tachycardia due to Propafenone Toxicity; Uncommon Side Effect of a Commonly Used Medication
Hammam Shereef1, Mohamedanwar Ghandour2, , Sarah Abdelsamad2, Ahmed Subahi3, Ahmed S Yassin3 and Luis Afonso3
1Department of Internal Medicine, Beaumont Hospital-Dearborn, Michigan, USA
2Division of Nephrology, Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, Michigan, USA
3Division of Cardiovascular Medicine, Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, Michigan, USA
Pub. Date: January 27, 2021
Cite this paper
Hammam Shereef, Mohamedanwar Ghandour, Sarah Abdelsamad, Ahmed Subahi, Ahmed S Yassin and Luis Afonso. A Classical Wide Complex Tachycardia due to Propafenone Toxicity; Uncommon Side Effect of a Commonly Used Medication.
American Journal of Medical Case Reports. 2021; 9(4):229-231. doi: 10.12691/AJMCR-9-4-6
Abstract
Propafenone is a Class 1 C anti-arrhythmic drug, frequently used in the treatment of supraventricular and ventricular arrhythmias. We herein are presenting a case of 67-year-old female who presented with wide complex tachycardia consistent with Propafenone toxicity and who responded immediately to sodium bicarbonate injections. This case shines the light on a common effect of Propafenone toxicity and aims to increase the clinician awareness about such a documented reaction, that can be reversed by a simple treatment like sodium bicarbonate.
Keywords
propafenone, tachycardia, atrial fibrillation
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/
References
[1] | Konety SH, Olshansky B . The "pill-in-the-pocket" approach to atrial fibrillation. N Engl J Med 2005; 352: 1150-1. |
|
[2] | Elsa-Grace Giardina. Major side effects of class I antiarrhythmic drugs. Uptodate updated on Jun 13, 2019. |
|
[3] | Amerini S, Bernabei R , Carbonin P , et al . Electrophysiological mechanism for the antiarrhythmic action of propafenone: a comparison with mexiletine. Br J Pharmacol 1988; 95: 1039-46. |
|
[4] | De Soyza N, Terry L, Murphy ML. Effect of propafenone in patients with stable ventricular arrhythmias. Am Heart J 1984; 108: 285-9. |
|
[5] | Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group. Podrid PJ1, Anderson JL. Am J Cardiol. 1996 Aug 15; 78(4): 430-434. |
|
[6] | Bayram Z, Güner A, Doğan C, Yılmaz F, Özdemir N. Severe cardiac toxicity following alcohol intake in a patient using therapeutic dose of Propafenone. Turk Kardiyol Dern Ars. 2017 Dec; 45(8): 752-754. |
|
[7] | Griffin JP, D’Arcy PF. A Manual of Adverse Drug Interactions. 5th edn. Amsterdam: Elselvier Science BV; 1997. |
|
[8] | Zel jković I, Bulj N, Kolačević M, Čabrilo V, Brkljačić DD, Manola Š. Failure of Intracardiac Pacing After Fatal Propafenone Overdose: A Case Report. J Emerg Med. 2018 Apr; 54(4): e65-e68. |
|